“Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders”, Swiss Med Wkly, vol. 132, no. 2930, pp. 414–414, Jul. 2002, doi: 10.4414/smw.2002.10031.